Treatments for advanced cancers are constantly evolving. Though there is an ongoing search for more selective agents and molecularly targeted approaches, combination systemic chemotherapy remains the foundation of therapy for multiple advanced cancer treatments.1 The common introduction of new chemotherapeutic agents, new drug combinations, and alterations in timing and dosage of delivery has the potential to create gaps in what the newest research shows is best practice and what may be occurring in the community.

This educational series will provide the latest clinical trial information and treatment guidelines for the management of some of the more challenging and prevalent advanced cancer types, including head & neck, gastric, non-small-cell-lung, prostate, and breast cancer. This educational program is intended for community oncologists and oncology nurses in order to provide their patients with the best care available.

1. Shaha A, Patel S. Head and Neck Cancer. In: Lenhard R, Osteen R, Gansler T, editors. Clinical Oncology.Atlanta: American Cancer Society; 2001.

Target Audience

This educational program is intended for community oncologists and oncology nurses.

Learning Objectives

At the conclusion of these activities participants should be able to:

  • Assess the safety and efficacy of currently used chemotherapeutic regimens
  • Evaluate the results of recent clinical trials and describe the schema for ongoing clinical trials
  • Explore emerging treatment options for metastatic disease in some of the more challenging and prevalent types of advanced malignancies
  • Discuss therapeutic decisions in a variety of case presentations in the treatment of metastatic solid tumors

CME/CE Information

The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Potomac Center for Medical Education designates this educational activity for a maximum of 1.25 AMA PRA Category I credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Physicians have the opportunity to earn up to 6.25 AMA PRA Category I credit(s)™ by completing this series.

Anthony J. Jannetti, Inc. (AJJ) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center (ANCC) Commission on Accreditation.

Educational design through the joint sponsorship of Anthony J. Jannetti, Inc. and Potomac Center for Medical Education.

Anthony J. Jannetti, Inc. designates this program for 1.25 CE contact hours. Participants should claim only those contact hours actually spent in the educational activity.

 

back to top